How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Collecting Vehicles Market
- By Vehicle Type: Mobile Blood Donation Vans, Blood Collection Buses, Blood Mobile Trailers, Motorcycle Blood Collection Units
- By Powertrain Type: Diesel Engine Vehicles, Electric Blood Collecting Vehicles, Hybrid Blood Collection Vehicles
- By Blood Collection Capacity: Small Capacity (1-5 Donors), Medium Capacity (6-15 Donors), High Capacity (16+ Donors)
- By Interior Configuration: Basic Blood Collection Setup, Advanced Apheresis Equipment Setup, Multi-Compartment Blood Processing Setup
- By End-User: Hospitals and Clinics, Blood Banks and Donation Centers, Non-Governmental Organizations (NGOs), Government Health Departments
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Mobile Blood Donation Vans leads By Vehicle Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.173 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.181 →
Full report · locked preview
Everything inside the Blood Collecting Vehicles Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Vehicle Type 4
Powertrain Type 3
Blood Collection Capacity 3
Interior Configuration 3
End-User 4
Companies profiled
Fresenius Kabi AG
Haemonetics Corporation
Terumo Corporation
Grifols
S.A.
Macopharma
Sartorius AG
Baxter International Inc.
Nipro Corporation
B. Braun Melsungen AG
Fenwal Inc.
Miltenyi Biotec
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Fresenius Kabi AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Haemonetics Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Terumo Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Grifols
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →S.A.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Macopharma
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Baxter International Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nipro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Fenwal Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Miltenyi Biotec
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cytiva (part of Danaher Corporation)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Helmer Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Helios Medical Products
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Sangart
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →
Global · 2025–2033
$1,351M by 2033 · 10.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Mobile Blood Donation Vans57.4
- Blood Collection Buses13.0
- Blood Mobile Trailers15.0
- Motorcycle Blood Collection Units14.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$207.6M → $418.5M · 9.2%
Europe$144.7M → $326.3M · 10.7%
Asia Pacific$132.1M → $274.4M · 9.6%
Latin America$81.8M → $188.0M · 11.0%
Middle East and Africa$62.9M → $130.0M · 9.5%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.982026
9.992027
10.002028
10.022029
10.022030
10.032031
10.062032
10.072033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Fresenius Kabi AG19.3
- Haemonetics Corporation19.4
- Terumo Corporation5.4
- Grifols11.2
- S.A.11.1
- Macopharma5.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Vehicle Type10.9%
Powertrain Type11.3%
Blood Collection Capacity29.1%
Interior Configuration24.7%
End-User24.0%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe24.4
- Asia Pacific20.5
- Latin America14.1
- Middle East and Africa9.7
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Fresenius Kabi AG | 86 | 87 | 81 | 82 | 94 | 97 | 88 |
| Haemonetics Corporation | 71 | 90 | 90 | 79 | 90 | 72 | 82 |
| Terumo Corporation | 67 | 75 | 77 | 65 | 82 | 84 | 75 |
| Grifols | 59 | 62 | 77 | 65 | 69 | 70 | 67 |
| S.A. | 60 | 71 | 64 | 76 | 70 | 70 | 69 |
| Macopharma | 48 | 48 | 70 | 71 | 53 | 53 | 57 |
| Sartorius AG | 57 | 49 | 56 | 50 | 65 | 56 | 56 |
| Baxter International Inc. | 44 | 50 | 49 | 51 | 52 | 60 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Fresenius Kabi AG
- Haemonetics Corporation
- Terumo Corporation
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Fresenius Kabi AG | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Haemonetics Corporation | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Terumo Corporation | − | ◐ | ◐ | ◐ | ◐ | ◐ |
| Grifols | ◐ | ◐ | ◐ | ◐ | ◐ | ✓ |
| S.A. | ◐ | ✓ | − | ◐ | − | ✓ |
| Macopharma | − | − | ◐ | ✓ | − | ◐ |
| Sartorius AG | ◐ | ◐ | ◐ | − | ◐ | − |
| Baxter International Inc. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Fresenius Kabi AG88
2Haemonetics Corporation82
3Terumo Corporation75
4S.A.69
5Grifols67
6Macopharma57
7Sartorius AG56
8Baxter International Inc.51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Fresenius Kabi AGHaemonetics Corporation
Challenger3
Strong scale, closing on the leaders.
Terumo CorporationGrifolsS.A.
Contender1
Focused players with pockets of strength.
Macopharma
Niche2
Specialists in a single segment or region.
Sartorius AGBaxter International Inc.
Go-to-market strategy
Land Vehicle Type in North America, then scale across Blood Collecting Vehicles Market — a $175M beachhead inside a $2.42B market.
Beachhead (SOM)$175Mobtainable near-term
Serviceable (SAM)$955Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Mobile Blood Donation Vans
Best fit — highest urgency & budget in Vehicle Type.
Economic buyer76 fit
Blood Collection Buses
Strong fit — clear ROI and a fast path to value.
End user66 fit
Blood Mobile Trailers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Vehicle Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Powertrain Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Blood Collection Capacity
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel28%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Vehicle Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Collecting Vehicles Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified24%
Evaluation12%
Closed-won5%
$16.8KCAC
$82KLTV
4.9:1LTV : CAC
< 4 moCAC payback
Investment thesis
Blood Collecting Vehicles Market is a durable-growth opportunity — $7.61B by 2033, compounding at 8.8%.
TAM · 2025$3.87Btoday
TAM · 2033$7.61Bforecast
CAGR8.8%2027–2033
Cumulative$50.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.61BTotal addressable market
SAM$3.18BServiceable available market
SOM$576MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.8% CAGR
Demand compounds through 2033, outpacing GDP across Vehicle Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Vehicle Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.61BLarge & growingTAM by 2033 at 8.8% CAGR
$3.18BServiceable nowreachable with today’s model
$576MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.94BBear5.7% CAGR
$7.61BBase8.8% CAGR
$9.75BBull11.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Powertrain Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Collecting Vehicles Market — a $6.69B market by 2033. Plan: grow share from 9.3% to 15.3%.
Market size · 2033$6.69Btotal addressable
Market CAGR5.0%2027–2033
Target share15.3%from 9.3% today
Revenue ambition$1.02Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.3% | 15.3% | On track |
| Revenue | $585M | $1.02B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.2% | 45.4% | Ahead |
| Customer retention | 86.4% | 95.6% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Vehicle Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Powertrain Type capability
A defensible second engine — invest in Powertrain Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Vehicle Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Powertrain Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $149M capacity & capability investment
- Greenlight bolt-on M&A in Powertrain Type
- Authorise North America expansion plan
- Fund R&D program for Vehicle Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskBehind
- Regulatory / policy changeOn track
- Execution & talentOn track
Sales deck · value proposition
Win the Blood Collecting Vehicles Market conversation — a $4.71B market you can size, segment and defend in minutes.
Market size · 2033$4.71Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers989+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Vehicle Type
Goal Grow share in Vehicle Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$69K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Fresenius Kabi AGHaemonetics CorporationTerumo CorporationGrifolsS.A.MacopharmaSartorius AGBaxter International Inc.+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Collecting Vehicles Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Collecting Vehicles Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Collection Devices Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportBlood Collection Equipment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Manager Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBlood Collection Products for Veterinary Use Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBlood Collection System Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportBlood Collection Tube for Noninvasive Prenatal Testing (NIPT) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Tubes (BCT) Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportBlood Collection Tubes and Vials Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Component Extractor Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportBlood Conservation Device Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBlood Conversation System Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportBlood Culture Devices Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.